Treatment was initiated at 36 mg/day and patients ongoing with incremental increases of eighteen mg/day (36 to 108 mg/working day) depending on meeting certain enhancement criteria with satisfactory tolerability. At the final study visit, necessarily mean modify scores (LS Imply, SEM) to the investigator rating within the AISRS demonstrated that CO